20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Acute Coronary Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jakstas, V; Kupstyte-Kristapone, N; Lesauskaite, V; Tatarunas, V; Zaliunas, R; Zvikas, V | 1 |
| Gao, W; Guo, G; Zhou, B; Zu, L | 1 |
2 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Acute Coronary Syndrome
| Article | Year |
|---|---|
Factors associated with platelet reactivity during dual antiplatelet therapy in patients with diabetes after acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Blood Platelets; Cytochrome P450 Family 4; Diabetes Mellitus; Female; Humans; Hydroxyeicosatetraenoic Acids; Logistic Models; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors | 2020 |
Relationship between metabolites of arachidonic acid and prognosis in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Arachidonic Acid; Biomarkers; Case-Control Studies; Female; Follow-Up Studies; Humans; Hydroxyeicosatetraenoic Acids; Male; Middle Aged; Prognosis; Retrospective Studies; ROC Curve | 2016 |